Clinvest   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Springfield MO United States (2000)

Organization Overview

First Clinical Trial
2004
NCT00208065
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Clinvest, Inc. | Clinvest Research | Clinvest Research, LLC | David True